Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENASIDENIB for Leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 55 adverse event reports in the FDA FAERS database where ENASIDENIB was used for Leukaemia.

Most Reported Side Effects for ENASIDENIB

Side Effect Reports % Deaths Hosp.
Death 650 17.6% 650 14
Off label use 213 5.8% 26 35
Fatigue 202 5.5% 5 41
Nausea 197 5.3% 5 40
Acute myeloid leukaemia 163 4.4% 95 43
Hospitalisation 149 4.0% 2 145
Diarrhoea 144 3.9% 1 35
Decreased appetite 122 3.3% 3 35
Platelet count decreased 113 3.1% 3 45
Drug ineffective 108 2.9% 7 16
Differentiation syndrome 102 2.8% 19 66
Pneumonia 91 2.5% 14 69
Pyrexia 90 2.4% 9 71
Asthenia 89 2.4% 2 39
Full blood count decreased 75 2.0% 2 37

Other Indications for ENASIDENIB

Acute myeloid leukaemia (2,220) Product used for unknown indication (657) Myelodysplastic syndrome (304) Off label use (181) Myeloid leukaemia (58) Acute myeloid leukaemia recurrent (51) Cholangiocarcinoma (48) Glioma (34) Acute myelomonocytic leukaemia (32) Acute myeloid leukaemia (in remission) (31)

Other Drugs Used for Leukaemia

DASATINIB (654) VENETOCLAX (307) CYTARABINE (288) METHOTREXATE (282) IMATINIB (281) RUXOLITINIB (230) NILOTINIB (203) BOSUTINIB (191) VINCRISTINE (172) CYCLOPHOSPHAMIDE (153)

Related Pages

ENASIDENIB Full Profile All Leukaemia Drugs ENASIDENIB Demographics ENASIDENIB Timeline